Core Insights - As of November 10, a total of 108 stocks reached their 52-week highs, with notable performers including Taijin Holdings (08321), OKURA HOLDINGS (01655), and Hejia Holdings (00704) achieving high rates of 125.00%, 84.90%, and 53.57% respectively [1] Summary by Category 52-Week Highs - Taijin Holdings (08321) closed at 0.620 with a peak price of 0.900, marking a 125.00% increase - OKURA HOLDINGS (01655) reached a closing price of 0.280 and a high of 0.355, reflecting an 84.90% rise - Hejia Holdings (00704) had a closing price of 0.345 and a peak of 0.430, showing a 53.57% increase - Other notable stocks include Sanhe Chemical (00301) with a 41.67% increase and Aide New Energy (02623) with a 36.25% rise [1] 52-Week Lows - Wangshan Wangshui-B (02630) recorded a closing price of 52.850 and a low of 51.000, resulting in a -21.84% decrease - Eight Horses Tea (06980) had a closing price of 52.850 and a low of 51.100, reflecting a -10.98% decline - New Enjoy Times (08519) reached a low of 0.270, marking a -10.00% drop - Other significant declines include Jiujiang Bank (06190) at -8.99% and Kun Group (00924) at -6.98% [3][4]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 三和精化集團有限公司 呈交日期: 2025年11月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00301 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 | HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 | HKD | | 15,000,000 | 本月 ...

Core Viewpoint - ST长方 (300301.SZ) reported its Q3 2025 results, highlighting the presence of institutional investors holding a significant portion of its shares [1] Group 1: Institutional Holdings - As of October 27, 2025, two institutional investors disclosed their holdings in ST长方 A-shares, totaling 85.4175 million shares [1] - The total shares held by these institutional investors account for 10.29% of ST长方's total share capital [1] - The institutional investors include 南昌鑫旺资本企业 (Limited Partnership) and 共青城长方投资合伙企业 (Limited Partnership) [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 三和精化集團有限公司 呈交日期: 2025年10月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00301 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 | HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 | HKD | | 15,000,000 | 本月底 ...

Financial Performance - Total revenue for the six months ended June 30, 2025, increased by approximately 1.4% to approximately RMB 515.2 million compared to RMB 507.9 million for the same period in 2024[10]. - Gross profit for the same period increased by approximately 9.7% to approximately RMB 170.1 million, up from approximately RMB 155.0 million in 2024[14]. - Gross profit margin improved by approximately 8.2 percentage points to approximately 33.0% from 30.5% in the previous year[10]. - Loss attributable to owners of the Company for the period increased by approximately 1,476.5% to approximately RMB 11.4 million, compared to a profit of approximately RMB 0.83 million in 2024[10]. - Total comprehensive loss for the same period was approximately RMB 9.7 million, representing an increase of approximately 4,129.9% compared to RMB 0.24 million in 2024[15]. - Basic loss per share for the six months ended June 30, 2025, was approximately RMB 2.4 cents, compared to basic earnings per share of approximately RMB 0.2 cents in 2024[16]. - The Group reported a basic loss per share of approximately RMB 2.4 for the six months ended 30 June 2025, compared to a basic earnings per share of approximately RMB 0.2 for the same period in 2024[19]. - The company reported a loss before income tax of RMB 8,205,000, compared to a profit of RMB 2,708,000 in the same period last year[167]. - The net loss for the period was RMB 11,384,000, compared to a profit of RMB 827,000 in 2024[167]. - Total comprehensive loss attributable to the owners of the company was RMB 9,712,000, down from a gain of RMB 241,000 in the previous year[167]. Expenses and Costs - Employee benefit expenses were approximately RMB 79.6 million for the six months ended June 30, 2025, a decrease from approximately RMB 81.9 million for the same period in 2024, mainly due to a reduction in share-based payment expenses[22]. - Selling and distribution expenses increased from approximately RMB 83.3 million for the six months ended June 30, 2024, to approximately RMB 107.5 million for the same period in 2025, driven by higher advertising, freight charges, and salaries[36]. - Other income and gains decreased from approximately RMB 5.4 million for the six months ended June 30, 2024, to approximately RMB 2.3 million for the same period in 2025, mainly due to a reduction in unconditional government subsidies[35]. - Selling and distribution expenses rose to RMB 107,490,000, a 29% increase compared to RMB 83,306,000 in 2024[167]. Assets and Liabilities - As of June 30, 2025, the Group recorded net current liabilities of approximately RMB 343.8 million, an increase from RMB 317.5 million as of December 31, 2024, with a current ratio of approximately 0.49[49]. - The gearing ratio increased to approximately 1.24 as of June 30, 2025, up from 1.20 as of December 31, 2024, primarily due to a decrease in equity resulting from the loss for the period[50]. - Total bank borrowings and other borrowings amounted to approximately RMB 255.1 million as of June 30, 2025, slightly down from RMB 257.9 million as of December 31, 2024[70]. - Current liabilities rose to RMB 680,510,000, compared to RMB 644,984,000 at the end of 2024[170]. - Net assets decreased to RMB 205,411,000 from RMB 214,281,000 as of December 31, 2024[170]. - The Group's bank borrowings and other borrowings amounted to approximately RMB 255,091,000, due on demand or within one year[187]. - As of June 30, 2025, the Group had unutilized banking facilities of approximately RMB 98,076,000[195]. Corporate Governance and Compliance - The Board did not recommend the payment of an interim dividend for the six months ended June 30, 2025, consistent with the previous year[10]. - The Company has complied with the Corporate Governance Code provisions throughout the six months ended June 30, 2025, with one noted deviation regarding the roles of chairman and CEO[111]. - All Directors confirmed compliance with the Model Code for Securities Transactions during the six months ended June 30, 2025[116]. - The Group is not involved in any other material litigation or arbitration as of the reporting date[102]. - As of June 30, 2025, the Group was not aware of any non-compliance with relevant laws and regulations that had a significant impact on it[108]. Share Capital and Options - As of June 30, 2025, Mr. Chen Bingqiang holds a 67.89% interest in Sanvo Fine Chemicals Limited, representing 319,410,000 shares[123]. - A bonus issue of 42,750,000 shares was approved, with a ratio of one bonus share for every ten existing shares held[133]. - The Amended 2019 Share Option Scheme was updated on June 30, 2023, to align with new listing rules[132]. - As of June 30, 2025, a total of 15,158,000 share options remain outstanding under the Amended 2019 Share Option Scheme[138]. - The exercise price for share options under the Amended 2019 Share Option Scheme is set at HK$1.122[138]. - No share options were granted, exercised, lapsed, or cancelled during the six months ended June 30, 2025[139]. - The number of share options and share awards available for grant under the Share Schemes remained at 41,122,283 as of both January 1, 2025, and June 30, 2025[145]. Litigation and Claims - Guangdong Sanvo was ordered to pay approximately RMB 17.0 million to Zhongshan Hongtai for unsettled project sums and penalties, with additional costs leading to a total payable amount of approximately RMB 11.5 million after deductions[86]. - The litigation claim against Guangdong Hongzheng for approximately RMB 4.2 million is still pending, with no inspection report issued yet[87]. - The management believes that the provisions for the ongoing litigations are sufficient as of June 30, 2025[101]. - As of June 30, 2025, bank deposits of approximately RMB 4,699,000 are restricted due to ongoing litigation claims[90]. - A civil litigation claim against Sanvo Fine Chemicals (Guangdong) by Zhongshan Kaishun amounts to approximately RMB 2,253,000, with a total construction cost assessed at approximately RMB 3,180,000[90]. Strategic Initiatives - The Group successfully acquired land use rights in Puyang City, Henan Province, through the acquisition of 100% equity interest in Sanvo New Materials Group Limited, aiming to expand market reach to Central China[25]. - A new ERP system has been implemented to enhance online and offline management and big data analysis, including customer relationship management and product life cycle management[26]. - The Group aims to maintain flexibility in funding by keeping committed credit lines available and issuing new ordinary shares[65]. - The Group continues to take measures to boost sales, including direct promotion to end-users through live e-commerce[195]. - The Group is committed to reducing environmental pollution and effectively utilizing resources to minimize its impact on the environment[105].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 三和精化集團有限公司 呈交日期: 2025年9月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00301 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 | HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 | HKD | | 15,000,000 | 本月底法 ...

Group 1 - The total revenue of Sanhe Precision Chemical (00301.HK) increased by approximately 1.4% to around RMB 515 million for the six months ending June 30, 2025 [1] - The gross profit margin rose by approximately 8.2 percentage points to about 33.0%, compared to approximately 30.5% for the six months ending June 30, 2024 [1] - The loss attributable to owners for the period increased by approximately 1,476.5% to around RMB 11.4 million, compared to a profit of approximately RMB 830,000 for the six months ending June 30, 2024 [1] - The board of directors does not recommend the payment of an interim dividend for the six months ending June 30, 2025, consistent with the previous period [1]

三和精化(00301)发布截至2025年6月30日止6个月中期业绩，该集团取得收益5.15亿元，同比增加1.42%; 公司权益持有人应占亏损1138.4万元，去年同期则取得溢利82.3万元;每股亏损2.4分。 于2025年，本集团管理层致力于主要产品营销及毛利率控制。因此，本集团2025年上半年销售及毛利金 额分别约为5.152亿元及1.701亿元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對本公告全部或任何部分內容而 產生或因依賴該等內容而引致的任何損失承擔任何責任。 SANVO Fine Chemicals Group Limited 三和精化集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號：301） 二零二五年中期業績公告 三和精化集團有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此公佈本公司及其附屬 公司（統稱「本集團」）截至二零二五年六月三十日止六個月之未經審計綜合業績。本公告 載有本公司截至二零二五年六月三十日止六個月之中期報告全文，符合香港聯合交易所 有限公司（「聯交所」）證券上市規則關於中期業績初步公告所載資料的相關規定。 中期報告之刊發 本中期業績公告將會刊載於聯交所網站( www.hkexnews.hk ) 及本公司網站 (www.sanvo.com)。本公司截至二零二五年六月三十日止六個月之中期報告將於適當 時候寄派予股東，並於上述網站可供查閱。 承董事會命 三和精化集團有限公司 主席、行政總裁兼執行董事 陳炳强先生 香港，二零二 ...

Core Viewpoint - Sanhe Precision Chemical (00301.HK) anticipates a loss attributable to shareholders of approximately RMB 11.4 million for the six months ending June 30, 2025, representing an increase of about RMB 12.2 million or approximately 1476.5% compared to an unaudited profit of RMB 800,000 for the six months ending June 30, 2024 [1] Summary by Category - Financial Performance - The company expects a significant loss of RMB 11.4 million for the upcoming reporting period [1] - This marks an increase in loss of approximately RMB 12.2 million compared to the previous period's profit of RMB 800,000 [1] - Cost Factors - The primary reason for the increased loss is attributed to higher marketing, advertising, and promotional expenses during the period [1]